United Arab Emirates · Regional rules

A legal portfolio and glass sphere on a sunlit desk overlooking Dubai’s waterfront skyline.

Surrogacy in Dubai: territorial rules and unresolved legal questions

The short answer for Dubai

Dubai should not be presented as a confirmed surrogacy destination on the official material. The UAE federal assisted-reproduction law was amended by Federal Decree-Law No. 17 of 2023, but that amendment is not a blanket authorisation for every emirate or clinic. Abu Dhabi has a specific DoH Standard for Gestational Surrogacy V2, published in December 2025 and effective from April 2026. Dubai’s DHA Standard for Assisted Reproductive Medicine Centers, effective 28 February 2026, lists approved main and associated ART procedures in Appendix 5 but does not expressly list gestational surrogacy. Clause 11.8 says procedures outside the approved list are subject to DHA approval. This is a concrete regulatory issue, not proof of a categorical ban or that a case-specific approval route is available. No dedicated Dubai surrogacy standard or generally published approval pathway was located.

Before paying an agency, signing an agreement or starting treatment, obtain a written DHA response explaining how the proposed arrangement is classified under Appendix 5 and clause 11.8, whether case-specific approval is available, and which facility is authorised. Obtain independent UAE family- and health-law advice. Until this is confirmed, do not treat a general IVF/ART licence or the Abu Dhabi standard as sufficient.

Why the emirate matters

There are several legal layers, and they answer different questions. Federal legislation provides the general framework for medically assisted reproduction. Dubai’s competent health authority regulates facilities and procedures within its remit. Abu Dhabi has its own DoH standard for gestational surrogacy, limited by its stated scope to DoH-designated licensed hospitals and assisted reproductive technology (ART) clinics that meet the relevant licensing requirements. The intended parents’ nationality and country of residence may separately govern recognition of parentage, citizenship and travel documents.

The place of treatment and the authority responsible for the facility matter. Residence in Dubai, an agency’s Dubai address, or a clinic’s ability to provide ordinary IVF does not by itself establish permission to perform surrogacy. If a proposal involves more than one emirate, identify where each medical act will occur, which authority supervises each site, and which licence covers the exact service.

The federal framework is not a complete local pathway

Federal Law No. 7 of 2019 Concerning Medically Assisted Reproduction is the starting point for the federal framework. Federal Decree-Law No. 17 of 2023 amended that law. The amendment is an important part of the legal history, but a federal amendment is not the same thing as a complete, published operating protocol for every emirate. The applicable consolidated federal text, implementing regulations and later amendments must be read together with the standards and directions of the competent health authority.

Some public summaries still reproduce the 2019 law’s former list of prohibited practices. They should not be treated as a reliable statement of the current surrogacy position without checking the 2023 amendment and subsequent instruments. The safe question is narrower: what current rule and written approval authorise this exact procedure at this exact location?

Abu Dhabi has a specific published standard

DoH’s document is titled Standard for Gestational Surrogacy (Full Surrogacy), reference DOH/STD/GS/HFS-HWS/V1/2025, version V2. The official document metadata states that V2 was published in December 2025 and became effective in April 2026, with a revision date of December 2028. It applies to DoH-designated licensed hospitals and ART clinics that satisfy the licensing requirements for maternal, neonatal and ART services. DoH’s public ART programme also lists surrogacy among services offered at selected facilities in Abu Dhabi.

This gives Abu Dhabi a defined local administrative and clinical pathway. It does not create a nationwide permission and should not be used as a substitute for Dubai approval. V2 is the current version identified in the official material; eligibility thresholds, testing, embryo-transfer requirements, payment rules and any exceptions must be checked against V2 itself, not copied from the earlier V1 standard or a third-party summary.

What Dubai’s current DHA standard actually says

A DHA circular dated 25 March 2026 directs professionals and facilities under DHA jurisdiction to comply with the Standards for Assisted Reproductive Medicine Centers. The official standard is Version 1.0, issued on 31 December 2025 and effective from 28 February 2026; it replaces the previous Standards for Fertility Centers. Appendix 5 lists approved main and associated ART procedures, but does not expressly list gestational surrogacy.

Clause 11.8 states that procedures other than those approved under Ministerial Decision No. 134 of 2021 are subject to DHA approval. Accordingly, the standard does not establish surrogacy as a generally approved routine service. If the proposed arrangement is treated as a procedure outside the approved list, the clause points to DHA approval; the document alone does not establish whether a case-specific route is available or prove a categorical ban. No dedicated Dubai surrogacy standard or generally published case-approval pathway was located in the official public material. Ask DHA in writing to classify the exact proposed procedure, identify the approval route and confirm which licensed facility may provide it before paying or beginning treatment.

What the available documents establish

Use this matrix to keep the legal questions separate. “Published local pathway” means a specific official framework was located; it does not mean every intended parent is eligible or that every agreement will be enforceable.

Layer What was located Practical meaning
UAE federal Federal Law No. 7 of 2019, amended by Decree-Law No. 17 of 2023. Read the current consolidated text and implementing rules; do not infer a Dubai-specific approval from the amendment alone.
Abu Dhabi DoH gestational-surrogacy Standard V2, effective April 2026, for designated licensed facilities. A local process exists, subject to eligibility, DoH review and facility authorisation.
Dubai The DHA standard effective 28 February 2026 lists approved main and associated ART procedures in Appendix 5 but does not expressly list gestational surrogacy. Clause 11.8 subjects procedures outside the approved list to DHA approval. This does not establish blanket permission or a categorical ban. Obtain DHA’s written classification of the proposed procedure and any required case-specific approval before treatment.
Outside the UAE Nationality, residence and consular laws may affect parentage, citizenship and travel. Check the intended parents’ home-state rules separately before treatment.

Why Abu Dhabi approval does not automatically transfer to Dubai

The DoH standard expressly limits its scope to DoH-designated licensed facilities in Abu Dhabi. DHA regulates facilities within Dubai. A general ART licence, an IVF service listing, a referral agreement or an agency’s claim is not proof that a particular site is authorised to perform surrogacy. Equally, a DoH approval for an Abu Dhabi facility should not be assumed to authorise a procedure at a Dubai site.

Ask the provider to map the full treatment pathway: where eggs and sperm will be handled, where the embryo will be created, where transfer will occur, where pregnancy care will be provided, and where delivery and birth registration are planned. If any stage crosses an emirate boundary, obtain confirmation from each relevant authority about the facility, procedure and approval. A programme marketed as “UAE-wide” may still depend on a specific emirate’s regulator and approved sites.

How the published Abu Dhabi workflow operates

The current DoH Appendix A workflow is useful because it shows that the Abu Dhabi route is not merely a private contract between adults. The designated IVF facility first checks eligibility and conducts medical and psychological assessments of the intended parent or parents. It prepares a medical report, described in the workflow as approved by two consultants, and approaches the DoH Medical Committee. The facility must receive the required approval before moving to the next stages.

After approval, the facility communicates the next steps and the selection of a surrogate through approved agencies. The surrogate undergoes medical and psychological assessment. The parties sign a legal agreement attested by a Notary Public, and the final signed documents are submitted to the DoH committee for review and validation. The clinical phase then includes IVF, genetic testing and embryo transfer. If pregnancy is confirmed, a licensed maternity hospital provides antenatal care; the intended parents are expected to be physically present at delivery, and postnatal support is arranged. This summary describes Abu Dhabi’s published workflow, not a Dubai process.

Eligibility and medical conditions must be checked against V2

A standard for gestational or “full” surrogacy is not a blanket permission for every family-building arrangement. Intended parents and the surrogate must meet the current criteria, complete the required medical and psychological assessments, and obtain the approvals specified by the current standard. The medical reason for the intended mother not carrying a pregnancy, the source of the gametes, the surrogate’s suitability and the facility’s scope are all matters to verify before treatment.

Do not rely on age ranges, body-mass-index limits, obstetric-history thresholds, genetic tests or embryo-transfer limits copied from the earlier V1 document or from an unsourced clinic website. V2 is the relevant version for a new case as of this guide’s date. Ask the facility to provide the exact current clauses and explain whether the intended parent’s circumstances fall within a standard criterion or require committee review. Do not assume donor gametes, traditional surrogacy, elective sex selection or a non-medical arrangement is covered.

Agreement, consent and payment require separate review

The current Abu Dhabi workflow includes a legal agreement attested by a Notary Public. Notarisation is a formal step; it should not be treated as a guarantee that every clause is enforceable, that all disputes are resolved, or that a registry or foreign authority must accept the agreement. Before signing, have independent UAE-qualified counsel review consent, clinical decision-making, expenses and reimbursements, insurance, complications, pregnancy loss, multiple births, withdrawal, breach, death or incapacity, confidentiality, data access, dispute resolution, governing law and translations.

The material does not support a blanket statement that any payment model or commercial arrangement is lawful. Obtain the current V2 wording and a written explanation of what payments, expense reimbursements, intermediaries and agency fees are permitted. Require an itemised budget and refund terms, and do not pay on the strength of verbal promises. The surrogate should have independent advice and a genuine opportunity to consent without pressure; a private agreement cannot override mandatory healthcare rules or automatically bind a hospital or registry.

Parentage and birth registration are separate questions

Permission to perform a medical procedure does not, by itself, answer every question about legal parentage. The DoH workflow refers to a birth certificate being issued in accordance with the legal agreement, but that wording should not be read as a guarantee that every registry will accept the agreement as the sole document required or that the result will be recognised abroad. Before treatment, ask the competent facility and relevant registration authority to identify the exact documents, approvals and steps for birth notification, certificate issuance and any later correction.

Do not assume that the surrogate’s name will automatically be omitted, that the intended parents will automatically be recorded, or that a private contract settles custody, guardianship or parental responsibility. Those issues can be distinct. The answer may depend on the current local rules and the parties’ precise status. If marital status, nationality, residence or other material facts differ from the case the clinic usually handles, obtain a written case-specific answer rather than relying on a generic brochure.

Citizenship, passports and cross-border travel

UAE medical or administrative approval does not decide a child’s nationality, passport eligibility, entry permission or parentage recognition under another country’s law. Before treatment, contact the relevant consulate and obtain advice under the intended parents’ nationality and residence laws. Ask whether a child born through surrogacy is recognised, whether genetic evidence or a court order is needed, which parent may transmit citizenship, what birth and medical records are required, and whether apostille, consular legalisation or certified translation is necessary.

Plan separately for the child’s UAE birth registration, any passport or emergency travel document, immigration status and exit/re-entry route. Check whether any consent or document from the surrogate is required. Do not assume nationality follows genetic connection or intended-parent status automatically, and do not book non-refundable travel until the consular process and likely timing are confirmed. A delay in documents can affect hospital discharge, accommodation, insurance and travel arrangements.

Documents to collect before making a commitment

Keep one dated file containing the legal and clinical basis for the proposed route. At minimum, request:

  • The current consolidated Federal Law No. 7 of 2019 as amended by Federal Decree-Law No. 17 of 2023, plus the current implementing rules relevant to the proposed procedure.
  • The current DHA standard and a written DHA answer for a Dubai procedure; or the current DoH Standard V2 and confirmation that the proposed Abu Dhabi facility is designated and licensed for this service.
  • The facility’s licence, the exact authorised service, the case-approval process and a written eligibility assessment.
  • The proposed agreement, consent documents, independent-counsel details, expense/payment schedule, cancellation and refund rules, and insurance confirmation.
  • A written birth-registration plan, required medical and legal records, and advice on citizenship, passport, translation, legalisation and travel documents.
  • Contact details for the regulator, complaint route and the person responsible for maintaining medical, consent and approval records.

Questions to put to DHA, the clinic and counsel

Ask for written answers tied to the exact facility, participants and procedure. General statements such as “we work under UAE law” are not enough.

  • Appendix 5 of the DHA standard does not expressly list gestational surrogacy, and clause 11.8 addresses procedures outside the approved list. How does DHA classify this exact arrangement, what approval is required, and can it be issued in writing before treatment?
  • Does DHA require case-specific permission or committee approval? Which authority issues it, and can the facility show the required approval before treatment?
  • Is the facility authorised for surrogacy itself, rather than IVF or other ART services generally? Which procedure list and licence entry confirm this?
  • What eligibility, medical indication, gamete-source, testing and embryo-transfer conditions apply under the current text? Which exceptions require committee review?
  • Which agreement, notarial, court, registry and birth-notification documents must be completed before transfer and before delivery?
  • What rules govern agency involvement, expenses, compensation, refunds, insurance, disputes and the surrogate’s independent advice?
  • How will parentage, birth registration, nationality, passports and exit/re-entry be handled, and what is the formal remedy if approval is refused?

Warning signs in agency or clinic marketing

Treat marketing as a lead, not as legal evidence. Red flags include promises that surrogacy is “legal everywhere in the UAE”; assurances that no regulator approval is needed; guaranteed parentage, citizenship or passports; a clinic that shows only an IVF licence; refusal to identify the current DHA rule; reliance on the older 2025 V1 standard without addressing V2; or pressure to pay a non-refundable deposit before eligibility and authorisation are confirmed.

Other warning signs are a refusal to itemise payments or refund terms, discouraging independent legal advice for the surrogate or intended parents, requests to misstate residence or relationship status, and proposals to use an address or facility in another emirate to avoid a regulator’s rules. Do not falsify documents or bypass approvals. Those steps can create legal, medical, parentage and travel risks even if a treatment cycle is clinically possible.

A practical decision route

If the proposed procedure is in Dubai, pause before paying or signing. The DHA standard effective 28 February 2026 does not expressly list gestational surrogacy among the approved main and associated ART procedures in Appendix 5; clause 11.8 says procedures outside the approved list are subject to DHA approval. Ask DHA in writing how the proposed arrangement is classified, whether case-specific approval is available, what legal basis applies and which licensed facility may provide it. Until the authority and any required approval are confirmed, do not treat the route as cleared. This is not, by itself, proof of an absolute ban.

If the proposed procedure is in Abu Dhabi, obtain the current DoH V2 standard, confirm that the facility is designated and licensed, complete the stated eligibility and committee process, have the agreement independently reviewed and notarised as required, and settle birth-registration and foreign-document plans before embryo transfer. If a pregnancy or birth has already occurred, prioritise medical care and urgent family-law advice; preserve all approvals, consents, agreements, medical records and birth notifications, and contact the relevant registry and consulate. If an agency proposes a cross-emirate route, map each stage and obtain approval from the authority responsible for each site. The safe next step is a documented answer, not a deposit.

Official sources

Official sources. The linked law and standards should be checked in their current consolidated form before reliance.

  1. S1 — MOHAP — Federal Decree-Law No. (17) of 2023 amending Federal Law No. 7 of 2019
  2. S2 — UAE Legislation — Federal Law No. (7) of 2019 Concerning Medically Assisted Reproduction
  3. S3 — Department of Health, Abu Dhabi — Standard for Gestational Surrogacy (Full Surrogacy), Version V2
  4. S4 — Department of Health, Abu Dhabi — Assisted Reproductive Technology (ART) Program
  5. S5 — Dubai Health Authority — Circular CIR-2026-00000047, Standards for Assisted Reproductive Medicine Center
  6. S6 — Dubai Health Authority — Standards for Assisted Reproductive Medicine Centers, code DHA/HRS/HPSD/ST-72, Version 1.0
  7. S7 — Dubai Health Authority — Circular CIR-2023-00000179, Federal Decree-Law No. 17 of 2023

Source note: the current official DHA standard PDF was reviewed from DHA’s public website. Appendix 5 does not expressly list gestational surrogacy among approved main and associated ART procedures; clause 11.8 makes procedures outside the approved list subject to DHA approval. This does not definitively establish either a prohibition or an available approval route. Verify the current Arabic legislation and obtain a written DHA position before relying on this guide.

Current law, regulator approval and case-specific eligibility must be confirmed by qualified counsel. General legal information only; not a legal opinion for an individual case.

Last updated:

Author: Khachatrian Razmik, LL.M.

International surrogacy and parentage legal services — LEX SURROGACY by Lex Agency · Author profile · Editorial standards